Flagship Harbor Advisors’s Transmedics TMDX Stock Holding History

Flagship Harbor Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-504	Closed	-$61.3K	–	2056
2025 Q4	$61.3K	Buy	+504	New	+$63.2K	﹤0.01%	1007

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Flagship Harbor Advisors's TMDX Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 504 shares — an estimated $61.3K sold.

Flagship Harbor Advisors first reported a position in TMDX in Q4 2025 and held it in 1 quarter. The position peaked at $61.3K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Flagship Harbor Advisors reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Flagship Harbor Advisors sold 504 Transmedics shares in Q1 2026, an estimated $61.3K.
Flagship Harbor Advisors first reported a position in Transmedics in Q4 2025 and held it in 1 quarter.
Flagship Harbor Advisors's Transmedics position peaked at $61.3K in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.